Page last updated: 2024-08-24

imiquimod and Scleroderma, Limited

imiquimod has been researched along with Scleroderma, Limited in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Marden, G; Stawski, L; Trojanowska, M	1

Other Studies

1 other study(ies) available for imiquimod and Scleroderma, Limited

Article	Year
The Activation of Human Dermal Microvascular Cells by Poly(I:C), Lipopolysaccharide, Imiquimod, and ODN2395 Is Mediated by the Fli1/FOXO3A Pathway. Journal of immunology (Baltimore, Md. : 1950), 2018, 01-01, Volume: 200, Issue:1 Topics: Adult; Aminoquinolines; Cell Line; Dermis; Endothelium, Vascular; Female; Forkhead Box Protein O3; Humans; Imiquimod; Lipopolysaccharides; Male; Microvessels; Middle Aged; Oligodeoxyribonucleotides; Poly I-C; Proto-Oncogene Protein c-fli-1; RNA, Small Interfering; Scleroderma, Limited; Signal Transduction; Toll-Like Receptors; Transforming Growth Factor beta	2018

Article

Year

The Activation of Human Dermal Microvascular Cells by Poly(I:C), Lipopolysaccharide, Imiquimod, and ODN2395 Is Mediated by the Fli1/FOXO3A Pathway.

Journal of immunology (Baltimore, Md. : 1950), 2018, 01-01, Volume: 200, Issue:1

Topics: Adult; Aminoquinolines; Cell Line; Dermis; Endothelium, Vascular; Female; Forkhead Box Protein O3; Humans; Imiquimod; Lipopolysaccharides; Male; Microvessels; Middle Aged; Oligodeoxyribonucleotides; Poly I-C; Proto-Oncogene Protein c-fli-1; RNA, Small Interfering; Scleroderma, Limited; Signal Transduction; Toll-Like Receptors; Transforming Growth Factor beta

2018